Newsroom

In-person conference runs Oct. 6-8, 2026, with registration open until Oct. 5, 2026 Topics include next-generation cancer therapeutics and immunotherapies, protein modulators, emerging platforms and artificial intelligence models

HOUSTON, SEPTEMBER 15, 2026 ― The University of Texas MD Anderson Cancer Center and Springer Nature will co-host a conference to explore the latest research on cancer therapeutics, highlighting advances in...